7ILN

Group deposition for crystallographic fragment screening of SARS-CoV-2 nucleocapsid protein (CTD) -- Crystal Structure of SARS-CoV-2 nucleocapsid protein (CTD) in complex with Z2856434879 (Nprot-x0083)

Summary for 7ILN

• Entry DOI: 10.2210/pdb7iln/pdb
• Group deposition: Group deposition for crystallographic fragment screening of SARS-CoV-2 nucleocapsid protein (CTD) (G_1002353)
• Descriptor: Nucleoprotein, DI(HYDROXYETHYL)ETHER, 2-[(4-methyl-1H-imidazol-5-yl)methyl]-1,2,3,4-tetrahydroisoquinoline, ... (5 entities in total)
• Functional Keywords: diamond i04-1, pandda2, xchemexplorer, crystallographic fragment screening, sars-cov-2, nucleocapsid protein, n protein, viral protein
• Biological source: Severe acute respiratory syndrome coronavirus 2; More
• Total number of polymer chains: 1
• Total formula weight: 13512.26

Authors

Aschenbrenner, J.C.,Luptak, J.,Balcomb, B.H.,Marples, P.G.,Bellini, D.,Yu, C.W.,Douangamath, A.,Dias, A.,Powell, A.,Fearon, D.,James, L.,von Delft, F. (deposition date: 2025-08-11, release date: 2026-08-26)

• Primary citation: Luptak, J.,Aschenbrenner, J.C.,Balcomb, B.H.,Marples, P.G.,Bellini, D.,Yu, C.W.,Douangamath, A.,Dias, A.,Powell, A.,Fearon, D.,James, L.,von Delft, F.; Group deposition for crystallographic fragment screening of SARS-CoV-2 nucleocapsid protein (CTD); To Be Published,

Experimental method

X-RAY DIFFRACTION (1.73 Å)